BSEBeryl Drugs LtdLowNeutral
Announced Wed, 13 May · 17:45 IST

PROCEEDINGS OF EGM

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+3.2%1-day move
₹20.50
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+3.2-2.0-2.0-0.3-7.3+11.4+14.6+4.4
Up moveDown movePending
AI summary

Beryl Drugs Ltd held its 31st Extra-Ordinary General Meeting on 11 May 2026 at Kanchan Palace Community Hall, Indore. The meeting was chaired by Mr. Sudhir Sethi with 46 members present (quorum met). Three ordinary resolutions were passed: (1) regularization of Mr. Shailendra Pathak as Whole Time Director, (2) appointment of Mrs. Neha Sarda as Non-executive Independent Director, and (3) approval of material related party transaction with M/S. Aminova Infusions Pvt. Ltd. Voting was conducted via remote e-voting and poll, with CS Dipika Kataria appointed as scrutinizer. All resolutions passed successfully.

Likely market impact

The appointment of new directors strengthens the board structure, while the approved related party transaction with Aminova Infusions Pvt. Ltd. represents a material transaction requiring shareholder oversight. Shareholders should monitor disclosure of transaction terms.